| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $331.3M | -15.4% |
| R&D Expense | $41.4M | +7093.1% |
| SG&A Expense | $63.5M | +292.5% |
| Interest Expense | $15.8M | -17.2% |
| Pre-tax Income | $286.9M | -35.6% |
| Income Tax | $66.7M | -12.8% |
| Net Income | $220.3M | -40.3% |
| EPS (Basic) | $3.07 | -5.2% |
| EPS (Diluted) | $2.37 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $291.0M | +44.4% |
| Inventory | $55.9M | — |
| Current Assets | $443.5M | +41.4% |
| Total Assets | $1.23B | +32.9% |
| Current Liabilities | $135.0M | +2224.2% |
| Long-term Debt | $444.2M | +12.5% |
| Stockholders' Equity | $565.8M | +36.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $201.7M | -44.6% |
| Capital Expenditures | $67K | — |
| Investing Cash Flow | -$56.6M | -229.5% |
| Financing Cash Flow | -$55.6M | +87.7% |
| Free Cash Flow | $201.7M | -44.6% |
| -17.4% |